Product image of Elahere (Mirvetuximab Soravtansine) supplied by GNH India

Elahere

Active Ingredient:
Mirvetuximab Soravtansine
Origin:
EU

Elahere (Mirvetuximab Soravtansine)

Elahere (Mirvetuximab Soravtansine) is an advanced intravenous medication used for targeted therapy in specific cancer treatments. This innovative drug is designed to deliver precise treatment options for eligible patients.

Manufacturer / TM Owner

Abbvie Deutschland Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Elahere is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins on cancer cells, aiming to deliver a therapeutic effect. Patients and healthcare providers often explore 'what is Elahere used for' to understand its role in personalized cancer care.

Side Effects

  • Elahere may cause various effects, which can vary among individuals. Commonly reported effects include fatigue, nausea, and peripheral neuropathy. Patients should discuss potential effects with their healthcare provider to manage expectations and monitor their health.

Precautions & Warnings

  • Elahere should be handled with care, following the guidelines provided by healthcare professionals. It is important to store and administer this medication as directed to ensure safety and efficacy. Patients should inform their healthcare provider about any pre-existing conditions or allergies before starting treatment.

Avoid Interactions

  • Elahere may interact with other medications, including those that affect the immune system or blood cells. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of Elahere.

Frequently Asked Questions

Elahere is used in the treatment of specific types of cancer, targeting proteins on cancer cells for precise therapy.

Elahere is administered intravenously, typically in a clinical setting under the supervision of a healthcare provider.

Common effects of Elahere may include fatigue, nausea, and peripheral neuropathy, which should be discussed with a healthcare provider.

Patients should follow the guidelines provided by their healthcare provider, including proper storage and administration, and inform them of any pre-existing conditions or allergies.

Elahere may interact with other medications, including those that affect the immune system or blood cells, so patients should inform their healthcare provider about all medications they are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mirvetuximab Soravtansine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT